Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


HPS-122 - Assessment of drug use of oseltamivir phosphate for oral suspension powder

  • At: Copenhagen (Denmark) (2025)
  • Type: Poster
  • Poster code: HPS-122
  • By: LI, Min-fen (Department Of Pharmacy, E-da Hospital, China Taiwan)
  • Co-author(s): Ms Min-fen Li (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
    Mr. Yung-Chia Hsu (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
    Ms Chien-Tzu Liu (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
  • Abstract:

    Introduction
    Learn about the use of publicly funded oseltamivir phosphate oral suspension flu antiviral drug for children under 0-5 years of age to collect data and assess the reasonableness and safety of the use of flu-like flu in publicly-funded expanded conditions, including influenza-like symptoms, and in cases of influenza-like illness among..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 September 2025

FIP Congresses